Cutaneous adverse effects of biologic medications.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32357984.
- Also identified by DOI 10.3949/ccjm.87a.19119.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biologic therapies have become widely used but often cause cutaneous adverse effects. The authors discuss the cutaneous adverse effects of tumor necrosis factor (TNF) alpha inhibitors, epidermal growth factor receptor (EGFR) inhibitors, small-molecule tyrosine kinase inhibitors (TKIs), and cell surface-targeted monoclonal antibodies, including how to manage these reactions and when to refer to a dermatologist.
Medical subject headings
- Biological Products
- Drug-Related Side Effects and Adverse Reactions
- Patient Care Management
- Skin Diseases